RXD:NYE-ProShares UltraShort Health Care (USD)

ETF | Trading--Inverse Equity |

Last Closing

USD 12.5

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.02M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-18 )

Largest Industry Peers for Trading--Inverse Equity

ETFs Containing RXD

RLD:CA 0.00 % 0.61 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Inverse Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.04% 96% N/A 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.04% 96% N/A 73% C
Trailing 12 Months  
Capital Gain 18.34% 98% N/A 85% B
Dividend Return 2.76% 60% D- 52% F
Total Return 21.11% 98% N/A 85% B
Trailing 5 Years  
Capital Gain -54.24% 87% B+ 7% C-
Dividend Return 3.20% 74% C 6% D-
Total Return -51.04% 84% B 6% D-
Average Annual (5 Year Horizon)  
Capital Gain 67.39% 39% F 96% N/A
Dividend Return 68.88% 39% F 96% N/A
Total Return 1.49% 58% F 35% F
Risk Return Profile  
Volatility (Standard Deviation) 432.86% 63% D 3% F
Risk Adjusted Return 15.91% 52% F 35% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.